Authorities visit Roche China offices
May 23, 2014Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic
A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …
Novartis pays $200m for eye technology
May 22, 2014Sales and Marketing Novartis, eye technology, fovista, ophthotech, wet and
Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …
PM Society announces new co-chairs
May 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PRIME, farrow, jones, o'brien, pm society
The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
ABPI hires new head of Commercial
May 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Watson
The ABPI has appointed David Watson as its new head of Commercial, who will be reporting to the association’s Commercial …
‘Stop Alzheimer’s testing on animals’
May 22, 2014Research and Development, Sales and Marketing AZ, Alzheimer's, Pfizer, humane, langley
Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …
BMS and AbbVie get FDA lift
May 21, 2014Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma
Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …
Gilead price lambasted by US health insurers
May 21, 2014Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi
Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …
Rebranding and personnel news for Discovery London
May 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing holy, london discovery, medics, publicis
Publicis Healthcare-owned med comms firm Medicus International has been rebranded as Discovery London. Barbara Joly is the general manager of …
GAVI vaccine group call for $7.5 billion funding
May 20, 2014Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine
The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …
Medicus International rebrands as Discovery London
May 20, 2014Medical Communications, Sales and Marketing Medicus International, Publicis Healthcare
Publicis Healthcare-owned medical communications group Medicus International has rebranded to Discovery London, thereby officially joining the Discovery worldwide brand. Discovery …
Europe approves Janssen’s hep C drug Olysio
May 20, 2014Research and Development, Sales and Marketing Janssen, hepatitis C, sovaldi
Janssen-Cilag International’s Olysio has been given marketing authorisation in the European Union for the treatment of adults with hepatitis C …
Abbott makes Latin America move
May 20, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging
Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …
Boehringer and InterMune data on IPF drugs impress
May 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, InterMune, idiopathic pulmonary fibrosis
Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …
Braille phone launched by UK developer
May 19, 2014Manufacturing and Production, Medical Communications, Research and Development Apple
British technology firm OwnFone has launched what it says is the first commercially available Braille phone. The device, which shares …
Novartis agrees Gleevec patent deal
May 19, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent
Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …
AstraZeneca rejects Pfizer’s ‘final offer’
May 19, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover
AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …
Science left behind in Pfizer-AstraZeneca saga
May 18, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, Wellcome Trust, science
With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
